Previous 10 | Next 10 |
Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced today that the Company has taken sign...
Gainers: NeuroMetrix (NASDAQ: NURO ) +147% . More news on: NeuroMetrix, Inc., Sonnet BioTherapeutics Holdings, Inc., Neovasc Inc., Stocks on the move, , Read more ...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced that in r...
Second Sight Medical Products, Inc. (EYES) Q4 2019 Earnings Conference Call March 19, 2020 4:30 PM ET Company Participants Lisa Wilson – Investor Relations Will McGuire – President and Chief Executive Officer Pat Ryan – Chief Operating Officer John Blake ...
Second Sight (NASDAQ: EYES ): Q4 GAAP EPS of -$0.50 misses by $0.01 . Revenue of $0.49M (-72.3% Y/Y) beats by $0.02M . Press Release More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, ,
-- Received CE Mark Certification and U.S. Food and Drug Administration conditional approval for Argus 2s, next-generation wearables -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and market...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, will release its ...
Ra Medical Systems (NYSE: RMED ) appoints Will McGuire as Chief Executive Officer (CEO) and a member of Board of Directors, effective March 30. More news on: Ra Medical Systems, Inc., Second Sight Medical Products, Inc., Healthcare stocks news, Read more ...
- Mr. McGuire to Remain on Second Sight’s Board of Directors - - Company continues to advance its breakthrough neuro-modulation technology, the Orion® Visual Cortical Prosthesis System, aimed at providing useful artificial vision to millions of blind individuals - Sec...
Gainers: OpGen (NASDAQ: OPGN ) +49% . More news on: OpGen, Inc., Insmed Incorporated, Artelo Biosciences, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...